Clinical trial
Prediction of Left Ventricular Function Changes Using Low Dose Dobutamine Gated SPECT in Patients Referred for Viability Assessment: The DOGS (DObutamine Gated Spect)Study.
NCT00213746 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of Left Ventricular Function Changes Using Low Dose Dobutamine Gated SPECT in Patients Referred for Viability Assessment: The DOGS (DObutamine Gated Spect)Study.
- Lead sponsor
- University Hospital, Rouen
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- December 31, 2005
- Enrollment
- 75
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
coronary arteriosclerosis, heart failure, congestive, myocardial infarction, myocardial ischemia, myocardial stunning